Drawing for ONCOZENE

USPTO serial 85872453

ONCOZENE

Reviewed by CopyMark Law Group

Reg. 4544651Status 800Registered
Filing date
Status date
Registration date
Jun 3, 2014
Examiner
GRIFFIN, JAMES
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with ONCOZENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kelly P. McCarthy

Kelly P. McCarthy Sideman & Bancroft LLPOne Embarcadero Center, 22nd FloorSan Francisco, CA 94111United States

Goods and services

ClassDescriptionStatusFirst use
010Medical products, namely, embolic microspheres for use in endovascular therapy, for treatment of hypervascularized tumors and to control and prevent abnormal bleeding; Medical products, namely, embolic microspheres for embolization in the form of particles; Medical products, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical products, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical products, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical products, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical products, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical products, namely, embolic microspheres in the form of embolic particle implants; Medical products, namely, embolic microspheres for treating vascular anomalies of the bodyACTIVEJun 5, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2024NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Aug 19, 2024RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Aug 19, 202489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Aug 19, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 3, 2024E89RTEAS SECTION 8 & 9 RECEIVED—
Jun 3, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 22, 2020NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 22, 2020C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 21, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 5, 2020E815TEAS SECTION 8 & 15 RECEIVED—
Feb 5, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 6, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 3, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 27, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 27, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 27, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 3, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 30, 2014SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 29, 2014REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Apr 28, 2014CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 15, 2014SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 7, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 13, 2014IUAFUSE AMENDMENT FILED—
Mar 13, 2014EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 21, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 26, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 6, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 21, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 18, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 2, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 2, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 2, 2013ALIEASSIGNED TO LIE—
Oct 1, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 21, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 20, 2013DOCKASSIGNED TO EXAMINER—
May 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 14, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 14, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance